A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

Completed · Phase 2

Conditions studied: Anemia

In brief

This study will determine the appropriate dose and frequency of administration of sc Mircera maintenance therapy in dialysis patients with chronic renal anemia who were previously receiving sc epoetin alfa or beta. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.

Key facts

Study ID
NCT00364832
Run by
Hoffmann-La Roche
People needed
137
Starts
2001-10-01
Expected to finish
2005-07-01
Last updated by the study team
2016-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.